| Patents for C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465) |
|---|
| 05/19/2009 | US7534885 Characterized by the formation and isolation of intermediate compounds in salified form; by using the intermediate of the present process in the subsequent reductive passage, it is possible to obtain emtricitabine in a purity that allows its direct crystallization; viricides |
| 05/19/2009 | US7534794 Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
| 05/14/2009 | US20090124683 Mercaptan and seleno-mercaptan compounds and methods of using them |
| 05/13/2009 | EP1687301B1 Thiaepothilone for treating cancerous diseases |
| 05/13/2009 | CN101432276A Quinoline derivatives |
| 05/12/2009 | US7531695 Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 05/12/2009 | US7531559 Fungicidal 1,2,3 triazole derivatives |
| 05/07/2009 | WO2009058800A2 Synthesis of nucleosides |
| 05/06/2009 | EP2054411A1 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
| 05/05/2009 | US7528143 JAK family of protein tyrosine kinases inhibitors; N4-(4-Methoxy-phenyl)-N2-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-pyrimidine-2,4-diamine; angiogenic-associated disorders including solid tumors and cancer, eye disease, inflammation, psoriasis, viral infection; antiproliferative agents |
| 04/30/2009 | WO2007058850A3 Inhibitors of akt activity |
| 04/30/2009 | US20090111789 Chiral cis-imidazolines |
| 04/29/2009 | EP1828127A4 INSECTICIDAL BIS(SUBSTITUTED PHENYL)-1-äÝ4-(SATURATED HETEROCYCLYL-SUBSTITUTED)PHENYLMETHYL¨-(4-PIPERIDYL)üMETHANE DERIVATIVES |
| 04/28/2009 | US7524848 Diaza heterocyclic amide compounds and their uses |
| 04/28/2009 | US7524846 heterocylcyclic amines used for treating or preventing conditions ameliorated by monoamine reuptake such as vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 04/23/2009 | US20090105214 Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes |
| 04/15/2009 | CN101407513A Method for synthesizing nucleoside analogue |
| 04/15/2009 | CN100478331C Inhibitors of cathepsin s |
| 04/14/2009 | US7517994 Heterocyclic inhibitors of MEK and methods of use thereof |
| 04/14/2009 | CA2409841C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/14/2009 | CA2408934C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/14/2009 | CA2256007C Substituted heterocyclic benzocycloalkenes and their use as analgesic |
| 04/09/2009 | WO2009016218A3 Fungicide n-cycloalkyl-n-bicyclic-carboxamide derivatives |
| 04/09/2009 | US20090093451 IL-8 Receptor Antagonists |
| 04/07/2009 | US7514432 5-[5-(Benzo[b]thiophen-7-yloxy)-pentyloxy]-2-(tetrahydro-pyran-2-yloxymethyl)-4H-pyran-4-one; antiproliferative and antiangiogenic activities; to treat cancers (such as leukemia), ocular diseases and arthritis; excellent bioavailability and pharmacokinetic properties |
| 04/07/2009 | CA2383583C Benzopyran derivative |
| 04/07/2009 | CA2217737C Thf-containing sulfonamide inhibitors of aspartyl protease |
| 04/02/2009 | WO2009039582A1 A process for chiral resolution of 2-substituted 4-substituted 1,3-oxathiolanes |
| 04/02/2009 | US20090088456 2-Pyridinylethylcarboxamide derivatives and their use as Fugicides |
| 04/02/2009 | CA2700653A1 A process for chiral resolution of 2-substituted 4-substituted 1,3-oxathiolanes |
| 04/01/2009 | EP1653961A4 Inhibitors of akt activity |
| 03/26/2009 | WO2009037538A2 Process for the preparation of lamivudine form i |
| 03/25/2009 | CN101391997A Method for synthesizing emtricitabine intermediate |
| 03/19/2009 | WO2009034042A1 Novel benzooxazol- and benzooxathiol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/19/2009 | US20090075973 Benzo-fused heterocycles |
| 03/18/2009 | EP1456176B1 Improved compounds for generating chemiluminescence with a peroxidase |
| 03/17/2009 | US7504410 such as N-[3-[[5-bromo-4-[[3-[[[1-(trifluoromethyl)cyclobutyl]carbonyl]amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide; Chks (checkpoint kinases), Akts (protein kinases B) and Pdks (phosphoinositide-dependent kinases) inhibitors; antiproliferative agents |
| 03/17/2009 | US7504162 Heat resistance; forming film |
| 03/12/2009 | US20090066235 Aromatic amine derivative and organic electroluminescence device using the same |
| 03/11/2009 | EP2032639A2 Pyridinium salts for polymer composites and methods for their preparation |
| 03/11/2009 | EP2032542A2 Heterocyclic aspartyl protease inhibitors |
| 03/10/2009 | US7501416 Quinoxaline compounds and methods of using them |
| 03/10/2009 | US7501408 2-(R)-Cyclohexylmethyl-N-[1-(S)-methyl-2-(4-trifluoromethoxy-phenylamino)-ethyl]-4-oxo-4-thiomorpholin-4-yl-butyramide; selective in presence of at least one other cathepsin isozyme; antiinflammatory agent: arthritis, atherosclerosis |
| 03/10/2009 | US7501407 Amide substituted pyrimidine compound; antiarthritic agents; antiischemic agents; antidiabetic agents; inflammatory bowel disease; antiproliferative agents; antiallergens |
| 03/05/2009 | WO2008053496A4 An improved process for the manufacture of cis (-)-lamivudine |
| 03/05/2009 | US20090062307 aminopyrazine derivatives; ROCK inhibitors; 3-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)pyrazin-2-amine; antiinflammatory, antidiabetic, antiproliferative agents |
| 02/25/2009 | EP2027119A2 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 02/25/2009 | EP1027056B1 Alpha-ketoamide multicatalytic protease inhibitors |
| 02/24/2009 | US7494990 2-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors |
| 02/19/2009 | US20090048190 Antiviral activity and resolution of 2-hydroxymethyl-5(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| 02/18/2009 | EP1444210B1 Qunazoline derivatives as antitumor agents |
| 02/17/2009 | US7491723 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 02/11/2009 | CN101362752A Synthesis method of lamivudine intermediate |
| 02/10/2009 | US7488824 Process for the production of substituted nicotinic acid esters |
| 02/10/2009 | US7488737 Each compound having an azabicyclic ring attached via a ring N or amino group; neuroprotectants; neurodegenerative diseases, analgesics, psychological disorders; e.g. 5-Methoxy-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxamide; ligands for nicotinic acetylcholine receptors |
| 02/05/2009 | WO2009016218A2 Fungicide n-cycloalkyl-n-bicyclic-carboxamide derivatives |
| 02/05/2009 | WO2008150486A3 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
| 02/05/2009 | US20090036679 Method for resolving enantiomers from racemic mixture having chiral carbon in alpha position of nitrogen |
| 02/04/2009 | CN100457752C Pyridine derivatives useful for inhibiting sodium/calcium exchange system |
| 02/03/2009 | US7485644 hydroxy{(1S)-4-pyrimidin-2-yl-1-[({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)methyl]butyl}formamide; collagenase 3 inhibitor; tissue remodelling such as embryonic development, bone formation and uterine remodelling during menstruation |
| 01/28/2009 | EP2018367A1 Novel microbiocides |
| 01/27/2009 | US7482340 Pyridine derivatives useful for inhibiting sodium/calcium exchange system |
| 01/22/2009 | WO2009010260A2 Condensed anthranilamide insecticides |
| 01/21/2009 | EP1444211B1 Quinazoline derivatives as antitumor agents |
| 01/21/2009 | CN101351460A Aspartyl protease inhibitors |
| 01/15/2009 | WO2008053496A8 An improved process for the manufacture of cis (-)-lamivudine |
| 01/13/2009 | US7476682 N-substituted piperidine derivatives as serotonin receptor agents |
| 01/13/2009 | US7476673 4-[3-Hydroxyimino-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-propenyl]-benzoic acid; emphysema; respiratory system and skin disorder; acne and psoriasis; side effect reduction; improved pharmacology |
| 01/08/2009 | WO2009005338A2 Solid forms ult-i, ult-2 and ult-3 of emtricitabine |
| 12/31/2008 | EP2007758A1 A novel crystalline form of lamivudine |
| 12/31/2008 | CN101336241A Method for resolving enantiomers from racemic mixture having chiral carbon in alpha position of nitrogen |
| 12/23/2008 | US7468436 Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers |
| 12/18/2008 | US20080312292 Antipruritics |
| 12/17/2008 | EP2001478A1 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives |
| 12/11/2008 | WO2008150486A2 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
| 12/04/2008 | US20080300249 tyrosine kinase inhibitors such as 5-(3,3-Dimethyl-ureido)-3-heptyloxy-isothiazole-4-carboxylic acid amide, used for treating hyperproliferative disorders in mammals; anticarcinogenic agents; antiproliferative agents |
| 12/02/2008 | US7459556 Process for preparing substituted 8-azabicyclo[3.2.1]octan-3-ols |
| 12/02/2008 | US7459454 Aminopyrazine derivatives and compositions |
| 11/27/2008 | WO2008142376A1 Bicyclosulfonyl acid (bcsa) compounds and their use as therapeutic agents |
| 11/27/2008 | WO2008141485A1 A process for stereoselective synthesis of lamivudine |
| 11/27/2008 | WO2008053496A3 An improved process for the manufacture of cis (-)-lamivudine |
| 11/27/2008 | CA2688142A1 A process for stereoselective synthesis of lamivudine |
| 11/27/2008 | CA2687415A1 Bicyclosulfonyl acid (bcsa) compounds and their use as therapeutic agents |
| 11/25/2008 | US7456162 Benzofuran derivatives, their production and use |
| 11/19/2008 | CN101307048A Method for preparing lamivadin by stereoselectivity |
| 11/18/2008 | US7452997 Tetrahydro-indazole cannabinoid modulators |
| 11/13/2008 | WO2008114023A3 Phthalazinone derivatives |
| 11/13/2008 | US20080280873 Biaryl Substituted Pyrazinones as Sodium Channel Blockers |
| 11/11/2008 | US7449484 angiogenesis inhibitor; Tie2 receptor kinase inhibitors; 2-tert-Butyl-4-naphthalen-2-yl-5-pyridin-4-yl-imidazole;2-tert-Butyl-4-(6-Ethoxynaphthalen-2-yl)-5-pyridin-4-yl-imidazole;4-(2-tert-Butyl-5-(6-methoxy-naphthalen-2-yl)-3H-imidazol-4-yl)-pyridine; etc. |
| 11/11/2008 | US7449483 e.g. 2-(Ethyl-{4-[2-methyl-3-(4-trifluoromethyl-phenyl)-benzo[b]thiophen-6-yl]-butyl}-amino)-ethanol; 2,3-oxidosqualene-lanosterol cyclase inhibitor; antidiabetic, antitumor, antiproliferative agent; hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones |
| 11/05/2008 | CN100430390C Water-soluble triazole fungicide |
| 11/04/2008 | US7446114 minimal side effects, improved selectivity, potency, pharmacokinetics, and/or duration of action; 1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid {(1S,3R,5R)-8-[3-(4-methanesulfonylpiperazine-1-sulfonyl)propyl]-8-azabicyclo[3.2.1]oct-3-yl}amide; reduced motility of the gastrointestinal tract |
| 10/29/2008 | EP1984358A1 Method for resolving enantiomers from racemic mixture having chiral carbon in alpha position of nitrogen |
| 10/28/2008 | US7442702 Prostaglandin agonists |
| 10/23/2008 | US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 10/22/2008 | EP1417196B1 Dna-pk inhibitors |
| 10/22/2008 | CN101291928A 4-heteroarylmethyl substituted phthalazinone derivatives |
| 10/16/2008 | WO2008079988A3 Quinazolines for pdk1 inhibition |
| 10/16/2008 | US20080255143 Inhibitors of Akt Activity |
| 10/14/2008 | US7435822 Delta and mu opioid receptors modulators, agonist or antagonist; analgesics, immunosuppressants, antiinflammatory agents; 3-(Phenyl-thiophen-3-yl-methylene)-8-aza-bicyclo[3.2.1]octane; ; neurological and psychiatric conditions; drug and alcohol abuse,; gastritis; diarrhea; cardiovascular; respiratory |